Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
Authors
Keywords
-
Journal
Nature Reviews Gastroenterology & Hepatology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-14
DOI
10.1038/s41575-021-00566-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tropifexor, a highly potent FXR agonist, produces robust and dose-dependent reductions in hepatic fat and serum alanine aminotransferase in patients with fibrotic NASH after 12 weeks of therapy: FLIGHT-FXR Part C interim results
- (2020) K.J. Lucas et al. DIGESTIVE AND LIVER DISEASE
- Cilofexor, a Nonsteroidal FXR Agonist, in Non‐Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial
- (2020) Keyur Patel et al. HEPATOLOGY
- The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids
- (2020) Sarah Ducastel et al. Scientific Reports
- Bile acids mediate signaling between microbiome and the immune system
- (2020) Adrian Liston et al. IMMUNOLOGY AND CELL BIOLOGY
- A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
- (2020) Kris V. Kowdley et al. JOURNAL OF HEPATOLOGY
- Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
- (2020) Clarissa Campbell et al. NATURE
- Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
- (2020) Stephen A. Harrison et al. GASTROENTEROLOGY
- Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders
- (2020) Saul J. Karpen et al. Hepatology International
- A guide to plasma membrane solute carrier proteins
- (2020) Mattia D. Pizzagalli et al. FEBS Journal
- The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in Nonalcoholic Steatohepatitis
- (2020) Rohit Loomba et al. HEPATOLOGY
- Genetic and Microbial Associations to Plasma and Fecal Bile Acids in Obesity Relate to Plasma Lipids and Liver Fat Content
- (2020) Lianmin Chen et al. Cell Reports
- FXR mediates T cell-intrinsic responses to reduced feeding during infection
- (2020) Clarissa Campbell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
- (2020) Rohit Loomba et al. HEPATOLOGY
- The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC
- (2019) Michael Trauner et al. HEPATOLOGY
- Bile acid analogues are activators of Pyrin inflammasome
- (2019) Irina Alimov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NGM 282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis
- (2019) Stephen A. Harrison et al. HEPATOLOGY
- GS-03-Global real world evidence of sofosbuvir/velpatasvir as a simple, effective regimen for the treatment of chronic hepatitis C patients: Integrated analysis of 12 clinical practice cohorts
- (2019) Alessandra Mangia et al. JOURNAL OF HEPATOLOGY
- Contributing factors and outcomes of burn-associated cholestasis
- (2019) Christian de Tymowski et al. JOURNAL OF HEPATOLOGY
- Emerging roles of bile acids in mucosal immunity and inflammation
- (2019) Mei Lan Chen et al. Mucosal Immunology
- Liver injury and failure in critical illness
- (2019) Thomas Horvatits et al. HEPATOLOGY
- FGF19–FGFR4 Signaling in Hepatocellular Carcinoma
- (2019) Aroosha Raja et al. Cells
- Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study
- (2019) Michael Trauner et al. Lancet Gastroenterology & Hepatology
- Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review
- (2019) Junmin Song et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- The Pyrin Inflammasome in Health and Disease
- (2019) Oskar Schnappauf et al. Frontiers in Immunology
- Bile acid metabolites control TH17 and Treg cell differentiation
- (2019) Saiyu Hang et al. NATURE
- Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
- (2019) Aline Gottlieb et al. Cells
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
- (2019) Xinyang Song et al. NATURE
- Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial
- (2018) Ibironke Oduyebo et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
- (2018) Kris V. Kowdley et al. HEPATOLOGY
- NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Stephen A Harrison et al. LANCET
- Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis
- (2018) Sangwon Byun et al. Nature Communications
- Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice
- (2018) Jane M. Natividad et al. Nature Communications
- Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas
- (2018) Rune E. Kuhre et al. Molecular Metabolism
- Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH
- (2018) Samer Al-Dury et al. Frontiers in Pharmacology
- Bile Acids Activated Receptors Regulate Innate Immunity
- (2018) Stefano Fiorucci et al. Frontiers in Immunology
- Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies
- (2018) Stefania Cannito et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis
- (2018) Mary E. Rinella et al. JOURNAL OF HEPATOLOGY
- Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
- (2018) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- Role of TGR5 (GPBAR1) in Liver Disease
- (2018) Dieter Häussinger et al. SEMINARS IN LIVER DISEASE
- Role of bile acids in colon carcinogenesis
- (2018) Thi Thinh Nguyen et al. World Journal of Clinical Cases
- Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
- (2017) Na Jiao et al. GUT
- New therapeutic concepts in bile acid transport and signaling for management of cholestasis
- (2017) Michael Trauner et al. HEPATOLOGY
- Bile acids in nonalcoholic steatohepatitis: Pathophysiological driving force or innocent bystanders?
- (2017) Daniel Jahn et al. HEPATOLOGY
- The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
- (2017) Puneet Puri et al. HEPATOLOGY
- The ascending pathophysiology of cholestatic liver disease
- (2017) Peter L.M. Jansen et al. HEPATOLOGY
- Lithocholic Acid Stimulates IL-8 Expression in Human Colorectal Cancer Cells Via Activation of Erk1/2 MAPK and Suppression of STAT3 Activity
- (2017) Thi Thinh Nguyen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects
- (2017) Vanessa Legry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- nor Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
- (2017) Peter Fickert et al. JOURNAL OF HEPATOLOGY
- Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15
- (2017) Mei Zhou et al. JOURNAL OF HEPATOLOGY
- The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis
- (2017) Michele Biagioli et al. JOURNAL OF IMMUNOLOGY
- Topical Intestinal Aminoimidazole Agonists of G-Protein-Coupled Bile Acid Receptor 1 Promote Glucagon Like Peptide-1 Secretion and Improve Glucose Tolerance
- (2017) Manuel Lasalle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study
- (2017) Vinod S Hegade et al. LANCET
- Pathogenesis of Kupffer Cells in Cholestatic Liver Injury
- (2016) Keisaku Sato et al. AMERICAN JOURNAL OF PATHOLOGY
- Splenic dendritic cell involvement in FXR-mediated amelioration of DSS colitis
- (2016) Vittoria Massafra et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver Disease
- (2016) Emina Halilbasic et al. DIGESTIVE DISEASES
- Opposing effects of bile acids deoxycholic acid and ursodeoxycholic acid on signal transduction pathways in oesophageal cancer cells
- (2016) Mohamed M. Abdel-Latif et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis
- (2016) Carl-Philipp Hackstein et al. GUT
- Microbiota-induced obesity requires farnesoid X receptor
- (2016) Ava Parséus et al. GUT
- Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
- (2016) Juan P. Arab et al. HEPATOLOGY
- Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis
- (2016) Anna Baghdasaryan et al. JOURNAL OF HEPATOLOGY
- Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans
- (2016) Shogo Takahashi et al. JOURNAL OF LIPID RESEARCH
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis
- (2016) Natalia Gomez-Ospina et al. Nature Communications
- Novel bile acid therapeutics for the treatment of chronic liver diseases
- (2016) Vinod S. Hegade et al. Therapeutic Advances in Gastroenterology
- Bile Acid-Induced Toxicity in HepaRG Cells Recapitulates the Response in Primary Human Hepatocytes
- (2015) Benjamin L. Woolbright et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty Induce Long-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation
- (2015) Valentina Tremaroli et al. Cell Metabolism
- Bile Acid Signaling: Mechanism for Bariatric Surgery, Cure for NASH?
- (2015) Rohit Kohli et al. DIGESTIVE DISEASES
- Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders
- (2015) Michael Trauner et al. DIGESTIVE DISEASES
- Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases
- (2015) Suzanne Devkota et al. DIGESTIVE DISEASES
- Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
- (2015) Brian C. Ferslew et al. DIGESTIVE DISEASES AND SCIENCES
- Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein–Coupled Bile Acid Receptors
- (2015) Cheryl A. Brighton et al. ENDOCRINOLOGY
- Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
- (2015) Gideon M. Hirschfield et al. GASTROENTEROLOGY
- TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro
- (2015) Maria Reich et al. GUT
- Bile Acid Diarrhea: Prevalence, Pathogenesis, and Therapy
- (2015) Michael Camilleri Gut and Liver
- Sphingosine-1-phosphate receptor 2: A novel bile acid receptor and regulator of hepatic lipid metabolism?
- (2015) John Y.L. Chiang HEPATOLOGY
- Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice
- (2015) Alexander G. Miethke et al. HEPATOLOGY
- Cholestatic liver (dys)function during sepsis and other critical illnesses
- (2015) Marc Jenniskens et al. INTENSIVE CARE MEDICINE
- Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT)
- (2015) Elisa Lozano et al. JOURNAL OF CONTROLLED RELEASE
- New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond
- (2015) Ulrich Beuers et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- GLP-1: A Mediator of the Beneficial Metabolic Effects of Bariatric Surgery?
- (2015) Sean Manning et al. PHYSIOLOGY
- Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis
- (2015) Benjamin L. Woolbright et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies
- (2015) Sahil Gambhir et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease
- (2015) Christopher Leung WORLD JOURNAL OF GASTROENTEROLOGY
- Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
- (2015) Mohamed-Sami Trabelsi et al. Nature Communications
- Bile acid nuclear receptor FXR and digestive system diseases
- (2015) Lili Ding et al. Acta Pharmaceutica Sinica B
- The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid
- (2014) J. R. F. Walters et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids
- (2014) Sui Peng et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
- (2014) M. Zhou et al. CANCER RESEARCH
- TGR5: Pathogenetic Role and/or Therapeutic Target in Fibrosing Cholangitis?
- (2014) Verena Keitel et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
- (2014) Christine Heinzle et al. CURRENT PHARMACEUTICAL DESIGN
- The bile acid TGR5 membrane receptor: From basic research to clinical application
- (2014) Henri Duboc et al. DIGESTIVE AND LIVER DISEASE
- Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2
- (2014) Runping Liu et al. HEPATOLOGY
- TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation
- (2014) Alessia Perino et al. JOURNAL OF CLINICAL INVESTIGATION
- TGF-β-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells
- (2014) Antonella Carambia et al. JOURNAL OF HEPATOLOGY
- FXR is a molecular target for the effects of vertical sleeve gastrectomy
- (2014) Karen K. Ryan et al. NATURE
- EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation
- (2014) Hanane Lanaya et al. NATURE CELL BIOLOGY
- Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy
- (2014) Julian R. F. Walters Nature Reviews Gastroenterology & Hepatology
- IL-17A Synergistically Enhances Bile Acid–Induced Inflammation during Obstructive Cholestasis
- (2013) Kate M. O'Brien et al. AMERICAN JOURNAL OF PATHOLOGY
- Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit
- (2013) Michael Camilleri et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Bile acid receptors in non-alcoholic fatty liver disease
- (2013) Yuanyuan Li et al. BIOCHEMICAL PHARMACOLOGY
- Dendritic cells and liver fibrosis
- (2013) Adeeb H. Rahman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Human Insulin Resistance Is Associated With Increased Plasma Levels of 12 -Hydroxylated Bile Acids
- (2013) R. A. Haeusler et al. DIABETES
- Ursodiol and Colorectal Cancer or Dysplasia Risk in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Meta-Analysis
- (2013) Jonathan D. Hansen et al. DIGESTIVE DISEASES AND SCIENCES
- Nuclear receptors in bile acid metabolism
- (2013) Tiangang Li et al. DRUG METABOLISM REVIEWS
- Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo
- (2013) Magdalena S Mroz et al. GUT
- The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice
- (2013) Noémie Péan et al. HEPATOLOGY
- Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis
- (2013) Lars P. Bechmann et al. HEPATOLOGY
- TGR5 signalling inhibits the production of pro-inflammatory cytokines byin vitrodifferentiated inflammatory and intestinal macrophages in Crohn's disease
- (2013) Kazuaki Yoneno et al. IMMUNOLOGY
- Effect of Ursodeoxycholic Acid Use on the Risk of Colorectal Neoplasia in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
- (2013) Siddharth Singh et al. INFLAMMATORY BOWEL DISEASES
- Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease
- (2013) Rachel H. McMahan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils
- (2013) Lauren A. Licata et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Cocarcinogenic Effects of Intrahepatic Bile Acid Accumulation in Cholangiocarcinoma Development
- (2013) Elisa Lozano et al. MOLECULAR CANCER RESEARCH
- Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
- (2013) Shin Yoshimoto et al. NATURE
- Bile acid receptors as targets for drug development
- (2013) Frank G. Schaap et al. Nature Reviews Gastroenterology & Hepatology
- The Bile Acid Sensor FXR Is Required for Immune-Regulatory Activities of TLR-9 in Intestinal Inflammation
- (2013) Barbara Renga et al. PLoS One
- High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia
- (2012) L. Lindström et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Bile acids: From digestion to cancers
- (2012) Marine Baptissart et al. BIOCHIMIE
- Inhibition of farnesoid X receptor controls esophageal cancer cell growth in vitro and in nude mouse xenografts
- (2012) Baoxiang Guan et al. CANCER
- Combined Rifampicin and Ursodeoxycholic Acid Treatment Does Not Amplify Rifampicin Effects on Hepatic Detoxification and Transport Systems in Humans
- (2012) Hanns-Ulrich Marschall et al. DIGESTION
- Role of CAR and PXR in xenobiotic sensing and metabolism
- (2012) Yue-Ming Wang et al. Expert Opinion on Drug Metabolism & Toxicology
- Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
- (2012) Fanli Meng et al. GASTROENTEROLOGY
- Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver
- (2012) Claudia Cicione et al. HEPATOLOGY
- Bile acids induce monocyte differentiation toward interleukin-12 hypo-producing dendritic cells via a TGR5-dependent pathway
- (2012) Riko Ichikawa et al. IMMUNOLOGY
- Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
- (2012) Derrick E. Fouts et al. JOURNAL OF HEPATOLOGY
- Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10 −/− mice
- (2012) Suzanne Devkota et al. NATURE
- Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models
- (2012) Dorothy M. French et al. PLoS One
- Correction: Release of ATP from Marginal Cells in the Cochlea of Neonatal Rats Can Be Induced by Changes in Extracellular and Intracellular Ion Concentrations
- (2012) Yating Peng et al. PLoS One
- Pharmacological Activation of the Bile Acid Nuclear Farnesoid X Receptor Is Feasible in Patients with Quiescent Crohn's Colitis
- (2012) Fiona D. M. van Schaik et al. PLoS One
- Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis
- (2012) Yaron Ilan WORLD JOURNAL OF GASTROENTEROLOGY
- TGR5 potentiates GLP-1 secretion in response to anionic exchange resins
- (2012) Taoufiq Harach et al. Scientific Reports
- Liver Dysfunction and Phosphatidylinositol-3-Kinase Signalling in Early Sepsis: Experimental Studies in Rodent Models of Peritonitis
- (2012) Peter Recknagel et al. PLOS MEDICINE
- Bile Acids Induce Inflammatory Genes in Hepatocytes
- (2011) Katryn Allen et al. AMERICAN JOURNAL OF PATHOLOGY
- Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells
- (2011) Xiaofang Huo et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine
- (2011) Raffaella M. Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Nuclear receptor PXR, transcriptional circuits and metabolic relevance
- (2011) Chibueze A. Ihunnah et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
- (2011) Eric T. Sawey et al. CANCER CELL
- TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading
- (2011) Thijs W.H. Pols et al. Cell Metabolism
- FXR activation inhibits inflammation and preserves the intestinal barrier in IBD
- (2011) M. E. Wildenberg et al. GUT
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in mice
- (2011) Yan-Dong Wang et al. HEPATOLOGY
- Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2 −/− (Abcb4 −/− ) mouse cholangiopathy model by promoting biliary HCO 3− output
- (2011) Anna Baghdasaryan et al. HEPATOLOGY
- Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis
- (2011) Sigurd Lax et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of bile acids on the growth of human cholangiocarcinoma via FXR
- (2011) Jiaqi Dai et al. Journal of Hematology & Oncology
- Obesity, inflammation, and liver cancer
- (2011) Beicheng Sun et al. JOURNAL OF HEPATOLOGY
- Increased Activation of the Wnt/ -Catenin Pathway in Spontaneous Hepatocellular Carcinoma Observed in Farnesoid X Receptor Knockout Mice
- (2011) A. Wolfe et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling
- (2011) Tingting Li et al. MOLECULAR ENDOCRINOLOGY
- Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
- (2011) Rian M. Nijmeijer et al. PLoS One
- The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis
- (2011) Sabrina Cipriani et al. PLoS One
- FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
- (2011) S. Kir et al. SCIENCE
- Dose-Response of Five Bile Acids on Serum and Liver Bile Acid Concentrations and Hepatotoxicty in Mice
- (2011) Peizhen Song et al. TOXICOLOGICAL SCIENCES
- The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance
- (2010) Tim C. M. A. Schreuder et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor
- (2010) D. L. H. Smith et al. CARCINOGENESIS
- Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women
- (2010) Marleen Kars et al. DIABETES
- Bile salts and cholestasis
- (2010) Lucas Maillette de Buy Wenniger et al. DIGESTIVE AND LIVER DISEASE
- The biliary HCO3− umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies
- (2010) Ulrich Beuers et al. HEPATOLOGY
- High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial
- (2010) Ulrich F. H. Leuschner et al. HEPATOLOGY
- Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis
- (2010) Christine Gauglhofer et al. HEPATOLOGY
- A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- The PXR is a drug target for chronic inflammatory liver disease
- (2010) Karen Wallace et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells
- (2009) Min Kyung Baek et al. CANCER LETTERS
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- Sodium deoxycholate causes nitric oxide mediated DNA damage in oesophageal cells
- (2009) Arthur J. Jolly et al. FREE RADICAL RESEARCH
- Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation
- (2009) J. Miao et al. GENES & DEVELOPMENT
- New molecular insights into the mechanisms of cholestasis
- (2009) Martin Wagner et al. JOURNAL OF HEPATOLOGY
- The Bile Acid Sensor Farnesoid X Receptor Is a Modulator of Liver Immunity in a Rodent Model of Acute Hepatitis
- (2009) A. Mencarelli et al. JOURNAL OF IMMUNOLOGY
- The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
- (2009) P. Vavassori et al. JOURNAL OF IMMUNOLOGY
- Bile acid transporters
- (2009) Paul A. Dawson et al. JOURNAL OF LIPID RESEARCH
- Bile acids: regulation of synthesis
- (2009) John Y. L. Chiang JOURNAL OF LIPID RESEARCH
- Common Variants of ABCB4 and ABCB11 and Plasma Lipid Levels: A Study in Sib Pairs with Gallstones, and Controls
- (2009) Monica Acalovschi et al. LIPIDS
- Serum bile acid along with plasma incretins and serum high–molecular weight adiponectin levels are increased after bariatric surgery
- (2009) Hiroshi Nakatani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- (2009) Philippe Lefebvre et al. PHYSIOLOGICAL REVIEWS
- Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling
- (2009) Katryn Allen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Bile acids as endogenous etiologic agents in gastrointestinal cancer
- (2009) Harris Bernstein et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Bile acids: Chemistry, physiology, and pathophysiology
- (2009) Maria J Monte et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Expression and function of the bile acid receptor TGR5 in Kupffer cells
- (2008) Verena Keitel et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differential expression of influx and efflux transport proteins in human antigen presenting cells
- (2008) Claudia Skazik et al. EXPERIMENTAL DERMATOLOGY
- Bile Salts Control the Antimicrobial Peptide Cathelicidin Through Nuclear Receptors in the Human Biliary Epithelium
- (2008) Emilie D'Aldebert et al. GASTROENTEROLOGY
- Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-κB: New insights into hepatic inflammation
- (2008) Martin Wagner et al. HEPATOLOGY
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
- Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention
- (2008) Han Kiat Ho et al. JOURNAL OF HEPATOLOGY
- Targeting bile-acid signalling for metabolic diseases
- (2008) Charles Thomas et al. NATURE REVIEWS DRUG DISCOVERY
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
- (2008) Scott L. Friedman PHYSIOLOGICAL REVIEWS
- Bile Acids and the Membrane Bile Acid Receptor TGR5—Connecting Nutrition and Metabolism
- (2008) Charles Thomas et al. THYROID
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started